Free Newsletter
A key to controlling stress
A molecular mechanism at work during periods of stress may shed light on developing new therapies for post-traumatic stress disorder and other conditions. Researchers at UT Southwestern Medical Center say that mice which are vulnerable to stress experience an increase of nerve activity that requires dopamine. Less vulnerable mice express molecules that prevent the release of dopamine. The challenge will be developing new therapies without injuring the patient, which benefits from dopamine in one part of the brain while being injured by it in another.
- read the report from The Washington Post
Related Articles:
Role of protein in despair triggered by stress. Report
Enzyme may hold key to PTSD therapies. Report
Heart drug may help memories fade away. Report
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: